Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

sihuan pharmaceutical holdings group ltd. - SHPHY

SHPHY

Close Chg Chg %
4.36 0.04 0.92%

Closed Market

4.40

+0.04 (0.92%)

Volume: 250.00

Last Updated:

Aug 17, 2026, 1:34 PM EDT

Trade Now

Company Overview: sihuan pharmaceutical holdings group ltd. - SHPHY

SHPHY Key Data

Open

$4.40

 Day Range

4.40 - 4.40

52 Week Range

N/A - N/A

 Market Cap

$989.54M

Shares Outstanding

224.90M

 Public Float

N/A

Beta

0.00

 Rev. Per Employee

N/A

P/E Ratio

22.78

 EPS

$1.54

Yield

210.95%

 Dividend

$0.04

EX-DIVIDEND DATE

Jul 2, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

  

SHPHY Performance

1 Week
 
 0.00%
 
1 Month
 
 N/A
 
3 Months
 
 N/A
 
1 Year
 
 N/A
 
5 Years
 
 N/A
 

SHPHY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Sihuan Pharmaceutical Holdings Group Ltd. - SHPHY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
323.92M 262.60M 264.16M 364.20M
Sales Growth
-36.53% -18.93% +0.59% +37.87%
Cost of Goods Sold (COGS) incl D&A
116.50M 89.67M 101.79M 120.68M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
53.69M 30.62M 34.26M 29.80M
Depreciation
48.21M 27.74M 29.27M 23.97M
Amortization of Intangibles
5.48M 2.87M 4.99M 5.83M
COGS Growth
-10.85% -23.03% +13.51% +18.56%
Gross Income
207.42M 172.93M 162.37M 243.52M
Gross Income Growth
-45.37% -16.63% -6.11% +49.97%
Gross Profit Margin
+64.03% +65.85% +61.47% +66.87%
2022 2023 2024 2025 5-year trend
SG&A Expense
277.57M 200.21M 219.02M 188.92M
Research & Development
139.09M 81.53M 65.85M 40.52M
Other SG&A
138.48M 118.67M 153.17M 148.40M
SGA Growth
-11.51% -27.87% +9.40% -13.74%
Other Operating Expense
- - - -
-
Unusual Expense
241.58M (18.60M) (457.70K) (168.74K)
EBIT after Unusual Expense
(311.72M) (8.67M) (56.19M) 54.77M
Non Operating Income/Expense
39.85M 31.50M 37.00M 29.69M
Non-Operating Interest Income
21.80M 20.88M 24.39M 13.75M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
31.36M 38.01M 38.20M 28.04M
Interest Expense Growth
+69.52% +21.22% +0.49% -26.60%
Gross Interest Expense
31.64M 38.29M 38.41M 28.04M
Interest Capitalized
- 275.48K 270.57K 210.51K
Pretax Income
(303.24M) (15.19M) (57.40M) 56.42M
Pretax Income Growth
-403.38% +94.99% -277.79% +198.30%
Pretax Margin
-93.61% -5.79% -21.73% +15.49%
Income Tax
29.23M 13.61M 6.01M 32.24M
Income Tax - Current - Domestic
14.62M 8.49M 15.10M 33.82M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
14.60M 5.12M (9.09M) (1.58M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(344.47M) (36.37M) (65.52M) 25.79M
Minority Interest Expense
(54.94M) (28.75M) (35.42M) 794.05K
Net Income
(289.53M) (7.62M) (30.11M) 25.00M
Net Income Growth
-548.31% +97.37% -294.87% +183.03%
Net Margin Growth
-89.38% -2.90% -11.40% +6.86%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(289.53M) (7.62M) (30.11M) 25.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
(289.53M) (7.62M) (30.11M) 25.00M
EPS (Basic)
-1.2413 -0.0328 -0.1299 0.1096
EPS (Basic) Growth
-553.19% +97.36% -296.04% +184.37%
Basic Shares Outstanding
233.25M 232.43M 231.65M 228.01M
EPS (Diluted)
-1.2413 -0.0328 -0.1299 0.1096
EPS (Diluted) Growth
-555.69% +97.36% -296.04% +184.37%
Diluted Shares Outstanding
233.25M 232.43M 231.65M 228.17M
EBITDA
(16.46M) 3.34M (22.39M) 84.39M
EBITDA Growth
-114.60% +120.31% -769.82% +476.93%
EBITDA Margin
-5.08% +1.27% -8.48% +23.17%

Sihuan Pharmaceutical Holdings Group Ltd. in the News